You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CNV

Showing 1 - 25 of 499
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea

Active, not recruiting
  • AMD
  • Exudative Macular Degeneration
    • Bordeaux, France
    • +4 more
    Dec 2, 2022

    DNA Methylation Trial in Jinan (DNA methylation level, blastocyst biopsy and sequencing)

    Completed
    • DNA Methylation
    • CNV
    • Jinan, Shandong, China
      Shandong University
    Oct 1, 2022

    Learn More About How Drug Aflibercept Works in Canadian Reduced

    Active, not recruiting
    • Myopic Choroidal Neovascularization
    • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
    • Multiple Locations, Canada
      Many Locations
    Jul 25, 2022

    Choroidal Neovascularization Trial in Sao Paulo (bevacizumab)

    Completed
    • Choroidal Neovascularization
    • Sao Paulo, Brazil
      Hospital das Clínicas- University of Sao Paulo
    Jan 4, 2022

    Myopic Choroidal Neovascularisation Trial in Beijing (CM082)

    Suspended
    • Myopic Choroidal Neovascularisation
    • Beijing, China
      Peking Union Medical College Hospital
    Mar 7, 2021

    Home Retinal Imaging Using NOTAL-OCT V3.0

    Active, not recruiting
    • A. AMD Patients, Where at Least One Eye is With Active CNV, Presenting Retinal Fluid at the Enrolment Visit, Undergoing Active Anti-VEGF Treatment
      • Tel Aviv, Israel
        TLV Medical Center
      Dec 22, 2021

      Migraine Trial in Gaziantep (Migraine CNV)

      Completed
      • Migraine
      • Migraine CNV
      • Gaziantep, Şehitkamil, Turkey
        Medicine
      May 31, 2021

      Pathologic Myopia Trial in Lutsk, Mykolaiv, Odesa (Intravitreal injection)

      Recruiting
      • Pathologic Myopia
      • Intravitreal injection
      • Lutsk, Ukraine
      • +3 more
      Mar 23, 2022

      Reinterpretation of CNV With Unknown Significance:5-year

      Completed
      • Genetic Disease
      • +3 more
      • reinterpretation of CNV
      • Nancy, France
        Lorraine University
      Sep 29, 2020

      Neovascular (Wet) Age-related Macular Degeneration Trial (Aflibercept(BAY86-5321, Eylea))

      Not yet recruiting
      • Neovascular (Wet) Age-related Macular Degeneration
      • Aflibercept(BAY86-5321, Eylea)
      • (no location specified)
      Jul 22, 2022

      Retinal Structure With High Resolution Optical Coherence

      Recruiting
      • Macular Edema
      • CNV
      • Examination with an OCT device
      • Bern, Switzerland
      • +1 more
      Oct 4, 2021

      Trigeminal Neuralgia Trial (BIIB074, Placebo)

      Not yet recruiting
      • Trigeminal Neuralgia
      • (no location specified)
      Jun 11, 2021

      A Prospective, Multi-centre, Single-blinded Study of UroCAD for

      Recruiting
      • Urothelial Carcinoma
      • The level of CNV
      • Shanghai, Shanghai, China
        Changhai Hospital
      Sep 8, 2021

      AMD, nAMD, Wet Age-related Macular Degeneration Trial in United States (RGX-314 Dose 1, RGX-314 Dose 2, Aflibercept (EYLEA®))

      Recruiting
      • AMD
      • +5 more
      • RGX-314 Dose 1
      • +2 more
      • Encino, California
      • +16 more
      Jun 2, 2022

      A Prospective, Single-centre,Single-blinded Study of PROUD for

      Recruiting
      • Prostate Carcinoma
      • The level of CNV
      • Jinan, Shandong, China
        Urology Department of Qiluhospital
      Jan 6, 2021

      Angioid Streaks of Macula Trial in Mykolaiv, Odessa (Intravitreal injection)

      Recruiting
      • Angioid Streaks of Macula
      • Intravitreal injection
      • Mykolaiv, Ukraine
      • +2 more
      Feb 2, 2021

      Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Australia

      Completed
      • Age-related Macular Degeneration
      • +2 more
      • bevacizumab
      • ranibizumab
      • Hurstville, New South Wales, Australia
      • +8 more
      May 7, 2021

      Neovascular Age Related Macular Degeneration Trial in France (RTH258/Brolucizumab)

      Active, not recruiting
      • Neovascular Age Related Macular Degeneration
      • Nice, Cedex1, France
      • +39 more
      Jan 20, 2023

      Myopic Choroidal Neovascularisation Trial in Guangzhou (3+PRN, 6+PRN)

      Recruiting
      • Myopic Choroidal Neovascularisation
      • Guangzhou, Guangdong, China
        Zhongshan Ophthalmic Center
      Feb 8, 2022

      Inflammatory Choroidal Neovascularization Trial in Lyon (Aflibercept)

      Completed
      • Inflammatory Choroidal Neovascularization
      • Lyon, France
        Hospices Civils de Lyon / Hopital de la Croix Rousse
      Nov 6, 2019

      Neovascular Age-related Macular Degeneration Trial in Binningen (Brolucizumab 6 mg solution for intravitreal injection)

      Terminated
      • Neovascular Age-related Macular Degeneration
      • Brolucizumab 6 mg solution for intravitreal injection
      • Binningen, Baselland, Switzerland
        Vista Klinik
      Dec 8, 2021

      Non-invasive Optical Angiography in Age-related Macular

      Recruiting
      • Age Related Macular Degeneration
      • Non-invasive OCT based optical angiography
      • +3 more
      • Vienna, Austria
        Medical University of Vienna
      Jan 13, 2023

      Dry Age-related Macular Degeneration Trial (QA102/Placebo, QA102, Placebo)

      Not yet recruiting
      • Dry Age-related Macular Degeneration
      • QA102/Placebo
      • +2 more
      • (no location specified)
      Sep 8, 2022

      Early Screening of Epithelial Ovarian Cancer

      Not yet recruiting
      • Ovarian Cancer
      • +2 more
      • Fragmentomics
      • (no location specified)
      Jun 26, 2023

      The Diagnostic Observatory: Combating Diagnostic Wandering and

      Recruiting
      • Developmental Abnormality
      • Questionnaire to assess expectations of a diagnosis
      • +2 more
      • Dijon, France
        Chu Dijon Bourogne
      Jul 4, 2022